Alan H Auerbach (President and CEO) sold ~$99K of Puma Biotechnology
Scheduled in advanceLoading…
Traded Jan 7, 2026 · Filed Jan 9, 2026
The CEO of Puma Biotechnology sold $106K of Puma Biotechnology shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$105,893
Shares × reported transaction price
62 days after results of Nov 6, 2025, 50 days before results of Feb 26, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Alan H Auerbach (President and CEO) sold ~$99K of Puma Biotechnology
Scheduled in advanceDouglas M Hunt (See Remarks) sold ~$23K of Puma Biotechnology
Scheduled in advanceDouglas M Hunt (See Remarks) sold ~$29K of Puma Biotechnology
Scheduled in advance